The health care industry's biggest conference just finished up, and the Fool's health care team was keeping close watch. While much of the interest was focused on biotech outfits big and small, the industry's titans -- the big pharmaceutical companies -- made some noise of their own.
Our health care bureau chief Brenton Flynn paid close attention to what they had to say, particularly in terms of M&A plans, but hasn't changed his position on the elephant in the room -- the speculation around a big pharma Bausch & Lomb buyout.
